Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy

As immunotherapy progresses, GMP-grade cytokines are increasingly vital for enhancing the effectiveness of cell-based therapies. Cytokines such as Interleukin-2 (IL-2), which drives the expansion and activation of T cells in CAR-T cell therapies, Interleukin-7 (IL-7), which supports T cell survival and proliferation, and Interleukin-15 (IL-15), which stimulates the activity of natural killer (NK) cells and T cells, are key components in these therapeutic approaches. By meeting stringent regulatory standards, these GMP-grade cytokines ensure purity, consistency, and safety, making them crucial in developing scalable, effective treatments for diseases like cancer and autoimmune disorders.

This webinar explores the critical role of these cytokines in cell therapy, from their use in expanding immune cells to their impact on clinical manufacturing. Learn how GMP-grade cytokines are improving therapeutic outcomes while maintaining the highest levels of safety and quality in clinical applications.